scutellarin has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, H; Lin, ST; Qian, H; Wu, YG; Xia, LL; Zhou, D | 1 |
| Liu, GT; Tan, ZH; Wei, HL; Yu, LH | 1 |
2 other study(ies) available for scutellarin and Liver Diseases
| Article | Year |
|---|---|
Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Complications; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Erigeron; Flavonoids; Lipid Metabolism; Lipid Peroxidation; Liver Diseases; Male; Malondialdehyde; Plants, Medicinal; Rats; Rats, Sprague-Dawley | 2007 |
The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
Topics: Alanine Transaminase; Animals; Apigenin; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Concanavalin A; fas Receptor; Genes, fos; Genes, jun; Glucuronates; I-kappa B Proteins; Interferon-gamma; Liver Diseases; Male; Mice; Mice, Inbred ICR; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Protective Agents; RNA, Messenger; Tumor Necrosis Factor-alpha | 2007 |